Your browser doesn't support javascript.
loading
Chiral Sulfoxide-Induced Single Turn Peptide α-Helicity.
Zhang, Qingzhou; Jiang, Fan; Zhao, Bingchuan; Lin, Huacan; Tian, Yuan; Xie, Mingsheng; Bai, Guoyun; Gilbert, Adam M; Goetz, Gilles H; Liras, Spiros; Mathiowetz, Alan A; Price, David A; Song, Kun; Tu, Meihua; Wu, Yujie; Wang, Tao; Flanagan, Mark E; Wu, Yun-Dong; Li, Zigang.
Afiliação
  • Zhang Q; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Jiang F; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Zhao B; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Lin H; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Tian Y; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Xie M; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Bai G; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Gilbert AM; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Goetz GH; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Liras S; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Mathiowetz AA; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Price DA; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Song K; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Tu M; Cardiovascular and Metabolic Diseases Medicinal Chemistry, Pfizer, Inc., 620 Memorial Drive, Cambridge, MA, 02142, USA.
  • Wu Y; Department of Biology, Southern University of Science and Technology, Shenzhen, China.
  • Wang T; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Flanagan ME; Center for Chemistry Innovation and Excellence, Pfizer Inc., Eastern Point Road, Groton, CT, 06340, USA.
  • Wu YD; School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
  • Li Z; College of Chemistry, Peking University, Beijing, 100871, China.
Sci Rep ; 6: 38573, 2016 12 09.
Article em En | MEDLINE | ID: mdl-27934919
ABSTRACT
Inducing α-helicity through side-chain cross-linking is a strategy that has been pursued to improve peptide conformational rigidity and bio-availability. Here we describe the preparation of small peptides tethered to chiral sulfoxide-containing macrocyclic rings. Furthermore, a study of structure-activity relationships (SARs) disclosed properties with respect to ring size, sulfur position, oxidation state, and stereochemistry that show a propensity to induce α-helicity. Supporting data include circular dichroism spectroscopy (CD), NMR spectroscopy, and a single crystal X-ray structure for one such stabilized peptide. Finally, theoretical studies are presented to elucidate the effect of chiral sulfoxides in inducing backbone α-helicity.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Safrol / Conformação Proteica em alfa-Hélice Idioma: En Revista: Sci Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Safrol / Conformação Proteica em alfa-Hélice Idioma: En Revista: Sci Rep Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China